TY - JOUR
T1 - How donor selection criteria can be evaluated with limited scientific evidence
T2 - lessons learned from the TRANSPOSE project
AU - Mikkelsen, Christina
AU - Mori, Gaia
AU - van Walraven, Suzanna M
AU - Castrén, Johanna
AU - Zahra, Sharon
AU - MacLennan, Sheila
AU - Seidel, Kirsten
AU - Fontana, Stefano
AU - Veropalumbo, Eva
AU - Cannata, Livia
AU - Pupella, Simonetta
AU - Kvist, Maria
AU - Happel, Marjan
AU - Korkalainen, Piia
AU - Chandrasekar, Akila
AU - Paulus, Ulrike
AU - Bokhorst, Arlinke
AU - Wulff, Birgit
AU - Fernandez-Sojo, Jesus
AU - Eguizabal, Cristina
AU - Urbano, Fernando
AU - Vesga, Miguel Angel
AU - van Kraaij, Marian
AU - Merz, Eva-Maria
AU - van den Hurk, Katja
AU - Hansen, Morten Bagge
AU - Slot, Ed
AU - Ullum, Henrik
N1 - © 2020 International Society of Blood Transfusion.
PY - 2021/3
Y1 - 2021/3
N2 - BACKGROUND AND OBJECTIVE: Donor selection criteria (DSC) are a vital link in the chain of supply of Substances of Human Origin (SoHO) but are also subject to controversy and differences of opinion. Traditionally, DSC have been based on application of the precautionary principle.MATERIALS AND METHODS: From 2017 to 2020, TRANSPOSE (TRANSfusion and transplantation PrOtection and SElection of donors), a European research project, aimed to identify discrepancies between current DSC by proposing a standardized risk assessment method for all SoHO (solid organs excluded) and all levels of evidence.RESULTS: The current DSC were assessed using a modified risk assessment method based on the Alliance of Blood Operators' Risk-based decision-making framework for blood safety. It was found that with limited or diverging scientific evidence, it was difficult to reach consensus and an international standardized method for decision-making was lacking. Furthermore, participants found it hard to disregard their local guidelines when providing expert opinion, which resulted in substantial influence on the consensus-based decision-making process.CONCLUSIONS: While the field of donation-safety research is expanding rapidly, there is an urgent need to formalize the decision-making process regarding DSC. This includes the need for standardized methods to increase transparency in the international decision-making process and to ensure that this is performed consistently. Our framework provides an easy-to-implement approach for standardizing risk assessments, especially in the context of limited scientific evidence.
AB - BACKGROUND AND OBJECTIVE: Donor selection criteria (DSC) are a vital link in the chain of supply of Substances of Human Origin (SoHO) but are also subject to controversy and differences of opinion. Traditionally, DSC have been based on application of the precautionary principle.MATERIALS AND METHODS: From 2017 to 2020, TRANSPOSE (TRANSfusion and transplantation PrOtection and SElection of donors), a European research project, aimed to identify discrepancies between current DSC by proposing a standardized risk assessment method for all SoHO (solid organs excluded) and all levels of evidence.RESULTS: The current DSC were assessed using a modified risk assessment method based on the Alliance of Blood Operators' Risk-based decision-making framework for blood safety. It was found that with limited or diverging scientific evidence, it was difficult to reach consensus and an international standardized method for decision-making was lacking. Furthermore, participants found it hard to disregard their local guidelines when providing expert opinion, which resulted in substantial influence on the consensus-based decision-making process.CONCLUSIONS: While the field of donation-safety research is expanding rapidly, there is an urgent need to formalize the decision-making process regarding DSC. This includes the need for standardized methods to increase transparency in the international decision-making process and to ensure that this is performed consistently. Our framework provides an easy-to-implement approach for standardizing risk assessments, especially in the context of limited scientific evidence.
UR - https://www.scopus.com/pages/publications/85096849473
UR - https://www.scopus.com/inward/citedby.url?scp=85096849473&partnerID=8YFLogxK
U2 - 10.1111/vox.13028
DO - 10.1111/vox.13028
M3 - Article
C2 - 33191514
SN - 0042-9007
VL - 116
SP - 342
EP - 350
JO - Vox Sanguinis
JF - Vox Sanguinis
IS - 3
ER -